大规模单细胞 profiling 鉴定出 ATRNL1 在心房颤动中的作用。
Large-scale single-nuclei profiling identifies role for ATRNL1 in atrial fibrillation.
机构信息
Cardiovascular Disease Initiative & Precision Cardiology Laboratory, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA, USA.
出版信息
Nat Commun. 2024 Nov 19;15(1):10002. doi: 10.1038/s41467-024-54296-w.
Atrial fibrillation (AF) is the most common sustained arrhythmia in humans, yet the molecular basis of AF remains incompletely understood. To determine the cell type-specific transcriptional changes underlying AF, we perform single-nucleus RNA-seq (snRNA-seq) on left atrial (LA) samples from patients with AF and controls. From more than 175,000 nuclei we find that only cardiomyocytes (CMs) and macrophages (MΦs) have a significant number of differentially expressed genes in patients with AF. Attractin Like 1 (ATRNL1) was overexpressed in CMs among patients with AF and localized to the intercalated disks. Further, in both knockdown and overexpression experiments we identify a potent role for ATRNL1 in cell stress response, and in the modulation of the cardiac action potential. Finally, we detect an unexpected expression pattern for a leading AF candidate gene, KCNN3. In sum, we uncover a role for ATRNL1 which may serve as potential therapeutic target for this common arrhythmia.
心房颤动(AF)是人类最常见的持续性心律失常,但 AF 的分子基础仍不完全清楚。为了确定 AF 背后的细胞类型特异性转录变化,我们对 AF 患者和对照的左心房(LA)样本进行了单细胞 RNA 测序(snRNA-seq)。在超过 175,000 个核中,我们发现只有心肌细胞(CMs)和巨噬细胞(MΦs)在 AF 患者中有大量差异表达的基因。在 AF 患者的 CMs 中,Attractin Like 1(ATRNL1)表达过度,定位于闰盘。此外,在敲低和过表达实验中,我们确定了 ATRNL1 在细胞应激反应和心脏动作电位调节中的重要作用。最后,我们检测到一个主要的 AF 候选基因 KCNN3 的意外表达模式。总之,我们揭示了 ATRNL1 的作用,它可能成为这种常见心律失常的潜在治疗靶点。
相似文献
Nat Commun. 2024-11-19
Basic Res Cardiol. 2016-11
Am J Physiol Endocrinol Metab. 2019-10-29
JCI Insight. 2020-9-17
Sci China Life Sci. 2025-3
Cardiovasc Res. 2024-12-4
引用本文的文献
Bioengineering (Basel). 2025-2-4
本文引用的文献
Science. 2023-7-14
Nature. 2023-7
Nat Cardiovasc Res. 2022-3
Front Cell Dev Biol. 2022-3-31
Nat Rev Cardiol. 2022-9